PREDNISONE, Entyvio 300 mg powder for concentrate for solution for infusion, BUDESONIDE
MLN0002-3025
Phase 3 small_molecule active
Quick answer
PREDNISONE, Entyvio 300 mg powder for concentrate for solution for infusion, BUDESONIDE for Moderately to severely active Crohn's disease (CD) is a Phase 3 program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Moderately to severely active Crohn's disease (CD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active